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INTRODUCTION
  The information on the occurrence of cancer, and the risk 
of different cancers, are very important for the study of cancer. 
Since the establishment of Korea Central Cancer Registry 
(KCCR) Program in 1980, many efforts to present data on the 
incidence of cancers from reliable registries have been made 
in Korea (1). Population-based cancer registries provide valid 
estimates on the incidences of cancer in defined populations. 
There are four frontiers in terms of population-based cancer 
registry in Korea; the Kangwha, the Seoul, the Busan and the 
Daegu Cancer Registries, in that chronological order of 
establishment.
  In this paper, we describe an estimation of the incidence 
of cancers in Korea using national mortality data and 
incidence data from the four frontier regional cancer reg-
istries, which will appear in the Cancer Incidence in Five 
Continents Vol. VIII (2).
MATERIALS AND METHODS
  Using national mortality data (3) and data from the four 
regional cancer registries, we assumed that the logarithm of the 
incidence rate of a given cancer can be expressed as a linear 
function of the logarithm of mortality in each sex-age group. 
Separate models were fitted for 25 cancers, using the incidence 
and mortality data provided by the four cancer registries, and 
parameter estimators were applied to the national mortality data 
(source: World Health Organization, period 1998∼2000), in 
order to provide national incidence rates. Seven age groupings 
were used for the purpose of developing the model: 0-44, 45∼
49, ..., 70∼75+. The estimated number of cancer cases in the 
age group 0-44 was then split into 0-14 and 15-44 using 
proportions given by the cancer registries.
RESULTS
  The overall age-standardized incidence rates (ASR), ex-
cluding other malignant neoplasm of the skin, were 287.0 and 
163.1 per 100,000 for males and females, respectively (Table 
1, 2). Among males, stomach cancer was the most frequent 
(ASR 69.6), followed by lung cancers, including bronchus 
cancer (ASR 54.5), liver cancer (ASR 47.0) and colo-rectal 
cancer (ASR 25.2). The most frequent sites of cancer in 
females, by rank order, were stomach (ASR 26.8), breast (ASR 
20.1), uterine cervix (ASR 18.0), colo-rectum (ASR 15.9), lung 
Cancer Incidence in Korea
Hai-Rim Shin*, M.D.1,2, Yoon-Ok Ahn*, M.D.3, Jong-Myon Bae, M.D.1, Myung-Hee Shin, M.D.3, Duk-Hee
Lee, M.D.2, Choong-W on Lee, M.D.4, Heechoul Ohrr, M.D.5, Don-Hee Ahn, M.D.6, Jacques Ferlay7, 
Dornald Maxwell Parkin, M.D.7, Dae-Kyu Oh, M.D.8 and Jae-Gahb Park, M.D.1
1Headquarter of Korea Central Cancer Registry, National Cancer Center, 2Busan Cancer Registry, 3Seoul Cancer Registry,
4Daegu Cancer Registry, 5Kangwha County Cancer Registry, 6National Medical Center, 7International Agency for Research
on Cancer, France, 8Bureau of Health Promotion, Ministry of Health & Welfare, Korea
  Purpose: W e estim ated the incidence of cancer in  
Korea.
  Materials and Methods: The indicence of cancer was 
estimated using national mortality data, and the incidence
data from  four frontier regional cancer registries, 
including Kangwha, Seoul, Busan and Deagu. These four
registries served a population about seventeen m illion, 
which is alm ost 38%  of entire population in Korea.
  Results: The overall age-standardized incidence rates 
(ASR) were 287.0 and 163.1 per 100,000 for m ales and  
females, respectively. Among males, stomach cancer was
the m ost frequent (ASR 69.6), followed by lung cancers,
including bronchus cancer (ASR 54.5), liver cancer (ASR
47.0) and colo-rectal cancer (ASR 25.2). The most frequent
sites of cancer in fem ales, by rank order, were stom ach
(ASR 26.8), breast (ASR 20.1), uterine cervix (ASR 18.0),
colo-rectum  (ASR 15.9), lung (ASR 13.0) and liver (ASR  
12.0).
  Conclusion: It is hoped that these results will provide
valuable leads for cancer research and cancer control in
Korea. (Cancer Research and Treatm ent 2002;34:405-
408)
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(ASR 13.0) and liver (ASR 12.0).
  The age-specific incidence rates for the leading cancer sites 
in males and females are shown in Fig. 1 and 2, respectively. 
The overall rate of stomach cancer was highest, however, 
liver cancer in the 45∼54 age group among males was 
highest. Unlike other cancers, the incidence of breast cancer 
reached a maximum in females aged 45∼54, which de-
creased thereafter.
DISCUSSION
  Our presented results are the first estimation on the incidence 
of cancer in Korea. About 80% of the cases are from the 
Table 1. Age standardized cancer incidence by age group among males in Korea
ꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚ
ICD-9 Sites 0∼14 15∼44 45∼54 55∼64 65+ ASR (W)
ꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏ
140-5 140 Lip, 141 Tongue, 0.07 0.57 4.75 11.11 23.62 3.33
142 Salivary gland,
143∼145 Mouth
147 Nasopharynx 0.02 0.20 1.29 1.87 2.25 0.54
146, 8-9 146 Oropharynx, 0.02 0.14 1.63 5.27 22.64 2.25
148 Hypopharynx,
149 Pharynx unspecified
150 Oesophagus 0.04 0.22 6.98 36.69 68.71 8.62
151 Stomach 0.03 11.06 81.59 234.61 529.40 69.57
153-4 Colon rectum 0.06 3.91 32.55 82.40 190.83 25.23
155 Liver 0.54 9.62 94.46 183.41 251.99 47.01
157 Pancreas 0.05 0.72 7.85 27.12 67.93 8.11
161 Larynx 0.00 0.20 6.10 26.28 45.85 6.07
162 Bronchus, lung 0.10 2.57 37.30 166.45 512.75 54.45
172 Melanoma of skin 0.00 0.16 0.86 1.88 1.15 0.39
174 Breast
185 Prostate 0.02 0.09 0.90 12.76 95.53 7.71
186 Testis 0.58 0.55 0.54 0.02 0.46 0.51
188 Bladder 0.00 0.90 9.26 24.32 71.97 8.39
189 Kidney etc. 0.61 1.13 8.84 18.14 30.51 5.24
191-2 Brain, nervous system 1.90 1.84 3.97 6.89 12.11 3.22
193 Thyroid 0.07 1.16 5.27 4.42 3.97 1.73
200+202 Non-Hodgkin lymphoma 1.43 2.24 6.63 14.17 29.39 5.32
201 Hodgkin's disease 0.47 1.08 1.76 4.19 0.63 1.18
203 Multiple myeloma 0.00 0.35 1.87 6.30 16.24 2.00
204-8 Leukemia 4.27 2.74 4.37 7.65 14.59 4.62
All but 173 All but other skin 13.21 45.53 339.90 943.96 2148.33 286.96
ꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏ
Fig. 1. Age-specific incidence rates of four major cancers in males. Fig. 2. Age-specific incidence rates of six major cancers in females.
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registered data files of the KCCR, which operates by voluntary 
registration at teaching hospitals for the whole country. The 
number of KCCR-affiliated hospitals was 131 in 2001 (1).
  Since the need for a population-based cancer registry has 
been raised, in order to obtain reliable and fully representable 
incidence data, a population-based regional cancer registry in 
Kangwha (KHCR) county was first implemented in Korea in 
1983, which serves a population of 70,360. The data first 
appeared in the Cancer Incidence in Five Continents Vol. Vll, 
which was published by the International Agency for Research 
on Cancer, in 1997 (4). Subsequently, the Seoul Cancer Reg-
istry (SCR) was launched under the support of the Korean 
Foundation for Cancer Research in July 1991, and covered the 
City of Seoul, the capital of Korea (5). At present, it serves 
a population of 10,590,406, and has been supported by the 
Korean National Cancer Control Program since 1996. In 1995, 
the Busan Cancer Registry (BSCR) was started, which was has 
also been supported by the Korean National Cancer Control 
Program since 1996, and serves a population of 3,859,219 (6). 
The Daegu Cancer Registry (DCR), with the support of the 
Dong-San Medical Center in Daegu, was established in 1997, 
and serves a population of 2,453,056 (7).
  It is important to review the quality of data in terms of its 
completeness and validity. In fact, the quality of four regional 
cancer registry data had already been evaluated and accredited 
by the editors of the Cancer Incidence in Five Continents Vol. 
VIII (2).
  The cancer incidence rates were much higher in males than 
in females, With an overall male to female ratio of 1.8. 
Pharyngeal cancer had the highest male to female ratio (19.0), 
followed by bladder cancer (5.0), lung cancer (4.2), liver cancer 
(3.9) and Hodgkin's disease (3.2). The reason for this high male 
to female ratio is mostly related of the use of tobacco, with 
the exception of liver cancer. More epidemiological studies, to 
elucidate the patterns of cancer and the related risk factors, 
based on the incidence data are required.
  In conclusion, our results will provide valuable clues for 
cancer research, and for the development of a cancer control 
program in Korea.
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Table 2. Age standardized cancer incidence by age group among females in Korea
ꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚ
ICD-9 Sites 0∼14 15∼44 45∼54 55∼64 65+ ASR (W)
ꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏ
140-5 140 Lip, 141 Tongue, 0.10 0.45 1.58 3.86 15.28 1.78
142 Salivary gland,
143-145 Mouth
147 Nasopharynx 0.00 0.12 0.46 0.36 0.40 0.16
146, 8-9 146 Oropharynx, 0.00 0.03 0.01 0.21 1.16 0.11
148 Hypopharynx,
149 Pharynx unspecified
150 Oesophagus 0.00 0.08 0.52 1.68 8.23 0.80
151 Stomach 0.02 10.47 34.55 68.69 186.05 26.83
153-4 Colon Rectum 0.06 3.53 23.89 48.24 112.10 15.87
155 Liver 0.22 2.01 17.70 41.67 81.97 11.95
157 Pancreas 0.05 0.30 3.72 13.91 43.34 4.70
161 Larynx 0.00 0.05 0.31 1.52 5.00 0.53
162 Bronchus, lung 0.09 1.90 11.35 33.28 117.08 12.95
172 Melanoma of skin 0.00 0.14 0.65 0.64 0.63 0.23
174 Breast 0.02 15.56 66.24 53.11 27.22 20.13
180 Cervix uteri 0.01 11.40 38.99 57.96 58.94 17.96
182 Corpus uteri 0.02* 1.10* 4.10 6.56 10.43 9.12
183 Ovary etc. 0.44 3.95 12.18 17.36 17.04 5.76
188 Bladder 0.03 0.25 1.84 3.86 15.15 1.69
189 Kidney etc. 0.72 0.82 2.10 5.37 10.78 1.99
191-2 Brain, nervous system 2.01 1.59 2.84 4.64 7.42 2.51
193 Thyroid 0.11 4.38 15.02 18.43 22.28 6.60
200+202 Non-Hodgkin lymphoma 0.51 1.45 3.68 8.49 15.14 2.93
201 Hodgkin's disease 0.22 0.58 0.38 0.00 0.12 0.37
203 Multiple myeloma 0.00 0.13 1.34 3.36 8.38 1.06
204-8 Leukemia 3.07 2.09 3.45 5.44 7.83 3.21
All but 173 All but other skin 10.12 82.06 260.95 439.35 868.37 163.06
ꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏ
* data were replaced by those observed in the pooled cancer registries
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